Skip to content

A randomized, single-blind, parallel-controlled study on the efficacy and safety of acupuncture point embedding in the treatment of obesity

A randomized, single-blind, parallel-controlled study on the efficacy and safety of acupuncture point embedding in the treatment of obesity

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005990
Enrollment
Unknown
Registered
2022-05-10
Start date
2022-05-30
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Control group:Same needling but no implantation of threads

Sponsors

Shanghai Post and Telecommunication Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Overweight: 24.0 = BMI < 28.0; obese: BMI = 28.0 (2) Age between 18 and 70 years old, with no restriction on gender (3) Those who voluntarily participated in this study subject and signed the Informed Consent Form and cooperated with the treatment observation.

Exclusion criteria

Exclusion criteria: (1) Patients with secondary obesity with underlying diseases such as cortisolism, hypothyroidism, or islet cell tumors. (2) Patients who have received any weight loss treatment within the last three months. (3) Patients who have been exposed to acupuncture point burial therapy (4) Patients with serious circulatory, digestive, urinary, hematopoietic system disorders or malignancies, history of mental disorders (5) Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Weight;Body mass index;

Secondary

MeasureTime frame
High density lipoprotein cholesterol;Total cholesterol;Height;Low density lipoprotein cholestero;Waist;Body fat percentage;Triglyceride;

Countries

China

Contacts

Public ContactXiao Siqi

Shanghai Post and Telecommunications Hospital

Topivenxu@aliyun.com+86 13611600388

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026